The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials

EuroIntervention 2014;10:97-104 published online ahead of print September 2013. DOI: 10.4244/EIJV10I1A16

1. University Hospital Tübingen, Department of Cardiology, Tübingen, Germany; 2. The Medicines Company, Parsippany, USA; 3. Cleveland Clinic, Department of Cardiovascular Medicine, Cleveland, USA; 4. Icahn School of Medicine at Mount Sinai, New York, NY,

Aims: Percutaneous coronary intervention (PCI)-related risks are increased among patients with left main disease (LMD). The aim was to evaluate the impact of antithrombotic therapy on out

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Intracoronary electrocardiogram ST-segment elevation in patients with non-ST-segment elevation myocardial infarction and its association with culprit lesion location and myocardial injury